NCT02340000 - Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate | Biotech Hunter

Enrollment

315

Participants

Timeline

Start Date

November 18, 2014

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions

Sinusitis

Interventions

DRUG

standard dose amoxicillin/clavulanate

amoxicillin/clavulanate 875/125 + placebo bid x 7 days

DRUG

high dose amoxicillin/clavulanate

Time Period I: extended-release amoxicillin/clavulanate 1000/62.5 two tablets bid x 7 days Time Period 2: immediate-release amoxicillin/clavulanate 875/125 plus amoxicllin 875 bid x 7 days

Trial Locations (1)

12110

Albany Medical Center Internal Medicine and Pediatrics, Latham